Screener
Bio-Techne TECH Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056302
| Line item | Nine Months Ended / March 31, 2026 | Nine Months Ended / March 31, 2025 |
|---|---|---|
| Taxes paid on RSUs and net share settlements | (10,643) | (6,288) |
| Net cash provided by (used in) financing activities | (135,906) | (163,453) |
| Effect of exchange rate changes on cash and cash equivalents | (1,985) | (1,434) |
| Net change in cash and cash equivalents | 47,633 | (11,121) |
| Cash and cash equivalents at beginning of period | 162,186 | 151,791 |
| Cash and cash equivalents at end of period | $209,819 | $140,670 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid for income taxes | $42,355 | $55,899 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Bio-Techne's net change in cash?
- Bio-Techne (TECH) reported net change in cash of $36.94M in Q1 2026.
- How has Bio-Techne's net change in cash changed year-over-year?
- Bio-Techne's net change in cash increased by 200.2% year-over-year, from -$36.88M to $36.94M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Bio-Techne's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude